Condition: Venous Thromboembolism · Postpartum Period · Aspirin · Sponsor: University of Calgary
The goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non-inferior) to usual care low-molecular-weight heparin injections to prevent venous thromboembolism (VTE: blood clots in the legs or lungs) for postpartum individuals with VTE risk factors.
This description comes directly from the study's public registry record.
Leslie Skeith, MD · 403-944-5246 · laskeith@ucalgary.ca
Jill Baxter, BSc · 403-220-7103 · jbaxter@ucalgary.ca
Always discuss trial participation with your own doctor first.
| Association Hospitalière De Bruxelles Et De Schaerbeek - Centre Hospitalier Universitaire Brugmann | Brussels, Belgium | Not Yet Recruiting |
| Foothills Medical Centre | Calgary, Alberta, Canada | Recruiting |
| The Ottawa Hospital - General Campus | Ottawa, Ontario, Canada | Not Yet Recruiting |
| Hvidovre Hospital | Hvidovre, Capital Region, Denmark | Not Yet Recruiting |
| CHU de Nancy | Nancy, France | Not Yet Recruiting |
| APHP - Hôpital Port Royal | Paris, France | Not Yet Recruiting |
| CHU de Saint-Etienne | Saint-Etienne, France | Not Yet Recruiting |
| CHU de Toulouse | Toulouse, France | Not Yet Recruiting |
| Rotunda Hospital, RCSI Department of Obstetrics and Gynaecology | Dublin, Ireland | Not Yet Recruiting |
| UCD Centre for Human Reproduction, The Coombe Hospital | Dublin, Ireland | Not Yet Recruiting |
| Amsterdam UMC | Amsterdam, Netherlands | Not Yet Recruiting |
| Medical University of Warsaw | Warsaw, Poland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06494878